A triple bottom in A2 Milk (ASX:A2M): Time for a rebound?

Marc Kennis Marc Kennis, February 2, 2022

A2 Milk has fallen from grace, but better times are ahead

A2 Milk (ASX:A2M) is one of those former market darlings, like Appen (ASX:APX), that have fallen from grace in the last few years. With the disappearance of the Daigous, AM2’s lucrative distribution channel into China largely evaporated. Daigous are Chinese expatriates purchasing products from overseas and shipping them back to consumers in China. We recently spoke about A2M on AusBiz.

However, with new management in place and a fresh China strategy, we believe better times are ahead for A2M and its shareholders, especially given the current valuation.

 

GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER

 
The stocks is cheap on consensus EBITDA growth estimates

The shares are currently trading at EV/EBITDA multiples of 13.6x and 10.6x for FY23 and FY24 respectively. FY23 starts in 5 months. But looking at consensus estimates for those years, we can see the market is expecting EBITDA growth of 32.5% and 28%.

In other words, on our beloved EV/EBITDA-to-EBITDA-growth metric, A2M is trading at 0.42 and 0.38 for these years, pretty attractive!

 

The chart is showing multiple bottoms

When looking at the first A2M price chart below, we can see that, following the stock’s strong decline since mid-2020, it has found very solid support around the $5 level.

 

A2M

A2M five-year chart (Source: Tradingview)

 

In fact, zooming in on the last 10 months of trading we can see the stock has formed three bottoms in the $5.06-$5.30 range. We believe that is a very strong sign of a change in market sentiment for A2 Milk.

 

A2M last 10 months

Shorter term A2M price chart (Source: Tradingview)

 

 
How to play A2M?

Combined with the company’s strategic shift when it comes to targeting the important Chinese market, we believe the current share price levels offer solid investment opportunities. Firstly, for trading-oriented investors, we believe a trade up to around $7 should be feasible. Investors focused on the longer term could buy A2M to play the new China strategy that should play out in the next three years.

Whatever your investment strategy might be, we believe A2 Milk currently offers something for everyone, except for shorters.

 

Check out our recent chat with AusBiz on A2 Milk.

A2 Milk (ASX:A2M): New Formula For Success

Disclosure: Pitt Street Research/Stocks Down Under directors own shares in A2M.

 

Need more stock ideas?

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Avita Medical

Avita Medical (ASX:AVH): Will the FDA’s last minute Christmas present catapult it to new heights in 2025?

Avita Medical (ASX:AVH) received not one, but two Christmas presents from the FDA. On December 19, it announced 510(k) clearance…

Best ASX Stocks for 2025

Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!

Here are our 6 Best ASX Stocks for 2025!   Opthea (ASX:OPT) Its been a long wait, but 2025 will…

highest PE multiples

5 ASX stocks with the highest PE multiples and 5 ASX stocks with the lowest PE multiples!

5 ASX stocks with the highest PE multiples Note: All figures are in AUD and for FY25 unless otherwise stated…